UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006721
Receipt No. R000007944
Scientific Title Phase II study of Pemetrexed plus Bevacizumab (YCRG04) in exacerbation cases of Non-squamous Non-small cell lung cancer, previously treated with bevacizumab plus platinum-based chemotherapy.
Date of disclosure of the study information 2011/11/15
Last modified on 2017/01/30 12:51:24

No. Disposal Last modified on Item of update
1 Insert 2011/11/14 17:19:55
2 Update 2012/08/29 14:28:58 Key exclusion criteria
Key exclusion criteria
3 Update 2013/04/02 15:44:30 Email
4 Update 2013/05/27 11:25:04 Institutions
5 Update 2013/11/25 10:10:55 TEL
Email
6 Update 2014/11/17 09:59:00 Last follow-up date
7 Update 2014/11/17 10:01:51 Name of person sending information
Name of person sending information
8 Update 2016/11/17 15:45:56 Recruitment status
9 Update 2017/01/30 12:51:24 Recruitment status


Contact us.